Background Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) as
complications of acute myocardial infarction (AMI), heart failure (HF) or cardiac surgery are …

The occurrence of several geriatric conditions may influence the efficacy and limit the use of
drugs prescribed to treat chronic conditions. Functional and cognitive impairment, geriatric …

Background Cardiogenic shock (CS) and low cardiac output syndrome (LCOS) are
potentially life‐threatening complications of acute myocardial infarction (AMI), heart failure …

Desde la elaboración de las guías de práctica clínica en hipertensión arterial en enero del
año 2000 se han producido nuevas evidencias científicas que hay que tener en cuenta en …

Study objective Angiotensin-converting enzyme inhibitors (ACE-I) are considered safe, but
they are associated with characteristic side effects, namely cough and angioedema, usually …

We investigated the effects of atorvastatin on inflammation and cardiac events during the
inpatient period and initial 6-month follow-up in acute coronary syndrome (ACS) patients …

Left ventricular hypertrophy (LVH), present in 70–80% of patients at the start of dialysis,
results from chronic high blood pressure, volume overload, or both, in association with a …

The present study investigated the actions of des-aspartate-angiotensin I (DAA-I) on infarct
size and three early inflammatory events in acute myocardial ischemia-reperfusion injury in …

Several clinical trials have demonstrated that angiotensin-converting enzyme inhibitor
(ACEI) and angiotensin II type 1 receptor blocker (ARB) are equally effective in the treatment …

Collaterals to occluded coronary arteries have been observed early after the onset of acute
myocardial infarction (AMI). The pressure distal to the occluded segment of the culprit …